F-star Therapeutics, Inc.
FSTXDelisted Mar 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566373
F-star Therapeutics, Inc. was delisted on Mar 9, 2023; its insiders filed their last Form 4 on Mar 9, 2023; 59 institutions reported holding it in 13F filings for Q4 2022, worth $57.8M in total; Fairfax Financial was the only superinvestor holding it.
Holders of 5% or more of FSTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of F-star Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of F-star Therapeutics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
20 Schedule 13D and 13G filings on F-star Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 17, 2023 | Beryl Capital Management LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Ridgeback Capital Investments L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Ridgeback Capital Investments L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 15, 2022 | Rock Springs Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Atlas Venture Opportunity Fund I, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Boxer Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Ridgeback Capital Investments L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Point72 Asset Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 10, 20224:50 PM ET | GSK plc | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2022 | Merck KGaA | 13G/AOld format | – | – | – | SEC |
| May 26, 2021 | Cooperatieve AESCAP Venture I U.A. | 13D/AOld format | – | – | – | SEC |
| May 18, 2021 | Point72 Asset Management, L.P. | 13GOld format | – | New | – | SEC |
| May 17, 2021 | Boxer Capital, LLC | 13GOld format | – | New | – | SEC |
| May 17, 2021 | Rock Springs Capital Management LP | 13GOld format | – | New | – | SEC |
| Apr 9, 2021 | Ridgeback Capital Investments L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Ridgeback Capital Investments L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Biotechnology Value Fund L P | 13G/AOld format | – | – | – | SEC |
| Feb 3, 2021 | Atlas Venture Fund VII L P | 13GOld format | – | New | – | SEC |
| Feb 3, 2021 | Atlas Venture Opportunity Fund I, L.P. | 13GOld format | – | New | – | SEC |
| Feb 1, 2021 | Merck KGaA | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell F-star Therapeutics, Inc. shares.
No Form 144 notices for F-star Therapeutics, Inc. are on file.